DK23392D0 - Heterocykliske forbindelser, deres anvendelse og fremstilling - Google Patents

Heterocykliske forbindelser, deres anvendelse og fremstilling

Info

Publication number
DK23392D0
DK23392D0 DK92233A DK23392A DK23392D0 DK 23392 D0 DK23392 D0 DK 23392D0 DK 92233 A DK92233 A DK 92233A DK 23392 A DK23392 A DK 23392A DK 23392 D0 DK23392 D0 DK 23392D0
Authority
DK
Denmark
Prior art keywords
preparation
heterocyclic compounds
compounds
benzazepines
tetrahydro
Prior art date
Application number
DK92233A
Other languages
Danish (da)
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK92233A priority Critical patent/DK23392D0/da
Publication of DK23392D0 publication Critical patent/DK23392D0/da
Priority to RO94-01400A priority patent/RO116088B1/ro
Priority to KR1019940702944A priority patent/KR100255739B1/ko
Priority to PCT/DK1993/000041 priority patent/WO1993017012A1/en
Priority to DE69310353T priority patent/DE69310353T2/de
Priority to CZ19941988A priority patent/CZ288626B6/cs
Priority to UA94085741A priority patent/UA34451C2/uk
Priority to NZ249465A priority patent/NZ249465A/en
Priority to AT93905215T priority patent/ATE152450T1/de
Priority to RU94040719A priority patent/RU2114839C1/ru
Priority to ES93905215T priority patent/ES2102019T3/es
Priority to SK1000-94A priority patent/SK281390B6/sk
Priority to DK93905215.5T priority patent/DK0628039T3/da
Priority to HU9402434A priority patent/HU221314B1/hu
Priority to AU36265/93A priority patent/AU667878B2/en
Priority to JP5514460A priority patent/JPH07504172A/ja
Priority to CA002130678A priority patent/CA2130678C/en
Priority to EP93905215A priority patent/EP0628039B1/en
Priority to IL10465793A priority patent/IL104657A/en
Priority to ZA931099A priority patent/ZA931099B/xx
Priority to US08/238,996 priority patent/US5470850A/en
Priority to BG98993A priority patent/BG62208B1/bg
Priority to FI943875A priority patent/FI113770B/fi
Priority to NO19943123A priority patent/NO310193B1/no
Priority to GR970401543T priority patent/GR3023896T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92233A 1992-02-24 1992-02-24 Heterocykliske forbindelser, deres anvendelse og fremstilling DK23392D0 (da)

Priority Applications (25)

Application Number Priority Date Filing Date Title
DK92233A DK23392D0 (da) 1992-02-24 1992-02-24 Heterocykliske forbindelser, deres anvendelse og fremstilling
EP93905215A EP0628039B1 (en) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof
ES93905215T ES2102019T3 (es) 1992-02-24 1993-02-05 2,3,4,5-tetrahidro-1h-3-benzazepinas y sus sales de adicion farmaceuticamente aceptables.
DK93905215.5T DK0628039T3 (da) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1H-benzazepiner og farmaceutisk acceptable syreadditionssalte deraf.
PCT/DK1993/000041 WO1993017012A1 (en) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof
DE69310353T DE69310353T2 (de) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze
CZ19941988A CZ288626B6 (cs) 1992-02-24 1993-02-05 8-Substituované 5-(2,3-dihydrobenzofuran-7-yl)-7-hydroxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepiny, způsoby jejich přípravy, farmaceutický prostředek je obsahující a jejich použití
UA94085741A UA34451C2 (uk) 1992-02-24 1993-02-05 2,3,4,5-тетрагідро-1н-3-бензазепіни, що використовуються для лікування захворювань центральної нервової системи, спосіб їх одержання, фармацевтична композиція та спосіб лікування захворювань центральної нервової системи
NZ249465A NZ249465A (en) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepine derivative, preparation and pharmaceutical compostions thereof
AT93905215T ATE152450T1 (de) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze
RU94040719A RU2114839C1 (ru) 1992-02-24 1993-02-05 2,3,4,5-тетрагидро-1н-3-бензазепины, фармацевтическая композиция, способ лечения и способы получения
RO94-01400A RO116088B1 (ro) 1992-02-24 1993-02-05 Derivati de 2, 3, 4, 5-tetrahidro-1h-3-benzazepina, procedeu de obtinere a acestora si compozitie farmaceutica
SK1000-94A SK281390B6 (sk) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-benzazepíny, spôsob ich prípravy, farmaceutický prostriedok a použitie
KR1019940702944A KR100255739B1 (ko) 1992-02-24 1993-02-05 2,3,4,5-테트라하이드로-1h-3-벤즈아제핀과 약제학적으로 허용되는 이의 산 부가염 및 이들을 함유하는 약제학적 조성물
HU9402434A HU221314B1 (en) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzodiazepines and pharmaceutically acceptable acid additional salts thereof, pharmaceutical compositions containing them and process for their preparation
AU36265/93A AU667878B2 (en) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1H-3-benzazepines and pharmaceutically acceptable acid addition salts thereof
JP5514460A JPH07504172A (ja) 1992-02-24 1993-02-05 ２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピン及び医薬として許容されるそれらの酸添加塩
CA002130678A CA2130678C (en) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof
IL10465793A IL104657A (en) 1992-02-24 1993-02-09 Benzazepine derivatives their preparation and pharmaceutical compositions containing them
ZA931099A ZA931099B (en) 1992-02-24 1993-02-17 Heterocyclic compounds their use and preparation
US08/238,996 US5470850A (en) 1992-02-24 1994-05-06 2,3,4,5-tetrahydro-1H-3-benzazepines
BG98993A BG62208B1 (bg) 1992-02-24 1994-08-22 2,3,4,5-тетрахидро-1н-3-бензазепини, метод за получаванетоим, тяхното приложение и това на фармацевтично приемливите имприсъединителни с киселини соли
FI943875A FI113770B (fi) 1992-02-24 1994-08-23 Menetelmä farmakologisesti aktiivisten 5-(2,3-dihydrobentsofuran-7-yyli)-7-hydroksi-3-metyyli-2,3,4,5-tetrahydro-1H-3-bentsatsepiinien valmistamiseksi
NO19943123A NO310193B1 (no) 1992-02-24 1994-08-24 2,3,4,5-tetrahydro-1H-3-benzazepiner og farmasöytisk akseptable syreaddisjonssalter derav, farmasöytiske preparater somomfatter disse, samt anvendelse av dem til fremstilling avpreparatene
GR970401543T GR3023896T3 (en) 1992-02-24 1997-06-26 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK92233A DK23392D0 (da) 1992-02-24 1992-02-24 Heterocykliske forbindelser, deres anvendelse og fremstilling

Publications (1)

Publication Number Publication Date
DK23392D0 true DK23392D0 (da) 1992-02-24

Family

ID=8091236

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92233A DK23392D0 (da) 1992-02-24 1992-02-24 Heterocykliske forbindelser, deres anvendelse og fremstilling
DK93905215.5T DK0628039T3 (da) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1H-benzazepiner og farmaceutisk acceptable syreadditionssalte deraf.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK93905215.5T DK0628039T3 (da) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1H-benzazepiner og farmaceutisk acceptable syreadditionssalte deraf.

Country Status (23)

Country Link
EP (1) EP0628039B1 (cs)
JP (1) JPH07504172A (cs)
KR (1) KR100255739B1 (cs)
AT (1) ATE152450T1 (cs)
AU (1) AU667878B2 (cs)
BG (1) BG62208B1 (cs)
CA (1) CA2130678C (cs)
CZ (1) CZ288626B6 (cs)
DE (1) DE69310353T2 (cs)
DK (2) DK23392D0 (cs)
ES (1) ES2102019T3 (cs)
FI (1) FI113770B (cs)
GR (1) GR3023896T3 (cs)
HU (1) HU221314B1 (cs)
IL (1) IL104657A (cs)
NO (1) NO310193B1 (cs)
NZ (1) NZ249465A (cs)
RO (1) RO116088B1 (cs)
RU (1) RU2114839C1 (cs)
SK (1) SK281390B6 (cs)
UA (1) UA34451C2 (cs)
WO (1) WO1993017012A1 (cs)
ZA (1) ZA931099B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0750616B1 (en) * 1994-03-16 2001-05-30 CeNeS Limited Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
KR19990044648A (ko) * 1995-09-15 1999-06-25 한센 핀 베네드, 안네 제헤르 2,3,4,5-테트라히드로-1ｈ-3-벤즈아제핀 화합물의 산 부가염
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
JP4584831B2 (ja) * 2002-12-20 2010-11-24 グラクソ グループ リミテッド 神経系の疾患の治療用のベンズアゼピン誘導体
PL2912019T3 (pl) 2012-10-25 2021-11-02 Tetra Discovery Partners Llc Heteroarylowe inhibitory pde4
WO2015048407A1 (en) * 2013-09-26 2015-04-02 Tetra Discovery Partners, LLC Heteroaryl inhibitors of pde4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
DK325188D0 (da) * 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater

Also Published As

Publication number Publication date
CA2130678A1 (en) 1993-08-25
DE69310353T2 (de) 1997-10-02
FI943875A0 (fi) 1994-08-23
NO943123D0 (no) 1994-08-24
NO310193B1 (no) 2001-06-05
KR950700286A (ko) 1995-01-16
DE69310353D1 (de) 1997-06-05
EP0628039B1 (en) 1997-05-02
IL104657A (en) 1999-11-30
UA34451C2 (uk) 2001-03-15
GR3023896T3 (en) 1997-09-30
JPH07504172A (ja) 1995-05-11
HU9402434D0 (en) 1994-10-28
CA2130678C (en) 2004-04-20
FI113770B (fi) 2004-06-15
NZ249465A (en) 1996-02-27
AU3626593A (en) 1993-09-13
FI943875L (fi) 1994-08-23
SK100094A3 (en) 1995-04-12
RU2114839C1 (ru) 1998-07-10
ES2102019T3 (es) 1997-07-16
CZ288626B6 (cs) 2001-08-15
AU667878B2 (en) 1996-04-18
KR100255739B1 (ko) 2000-05-01
WO1993017012A1 (en) 1993-09-02
DK0628039T3 (da) 1997-12-08
BG62208B1 (bg) 1999-05-31
ATE152450T1 (de) 1997-05-15
SK281390B6 (sk) 2001-03-12
EP0628039A1 (en) 1994-12-14
IL104657A0 (en) 1993-06-10
ZA931099B (en) 1994-08-17
HUT71127A (en) 1995-11-28
NO943123L (no) 1994-08-24
BG98993A (bg) 1995-05-31
RU94040719A (ru) 1996-07-10
HU221314B1 (en) 2002-09-28
CZ198894A3 (en) 1995-10-18
RO116088B1 (ro) 2000-10-30

Similar Documents

Publication Publication Date Title
NO941052L (no) Benzimidazolforbindelser, deres anvendelse og fremstilling
DK0675886T3 (da) Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister
ATE211743T1 (de) Substituierte 3-aminochinuclidine
FI935701A0 (fi) Fluoralkoxibensylaminoderivat av kvaeve-innehaollande heterocykliska foereningar
PT100300B (pt) Derivados de aminas heterociclicas-ciclicas, nomeadamente derivados de benzisoxazole-piperidina
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
PL307741A1 (en) Derivatives of arylindene and heteroarylindene oxindole used as tyrosine kinase inhibitors
PH25571A (en) Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
DK0772603T3 (da) Substituerede pyrimidinforbindelser og deres anvendelse
DE69523155D1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
DK0737189T3 (da) Heterocycliske forbindelser til behandling af CNS-forstyrrelser og cardiovaskulære forstyrrelser
ATE53377T1 (de) 1-substituierte tetralinderivate, ihre herstellung und verwendung.
NO995431D0 (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
DE69530988D1 (de) Benzimidazolderivate mit dopaminerger wirkung
DK23392D0 (da) Heterocykliske forbindelser, deres anvendelse og fremstilling
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DK571989A (da) Hydroxy-1,2,3,4-tetrahydroaminoacridiner, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment